Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Aug 2016

Terra Simone Bsp, Jang Jin S, Bi Lintao, Kipp Benjamin R, Jen Jin, Yi Eunhee S, Boland Jennifer M

Abstract excerpt

Several targetable genetic alterations have been found in lung cancer, predominantly in adenocarcinomas, which have led to important therapeutic advancements with the advent of targeted therapy. In contrast, the molecular features and presence of targetable genetic abnormalities in pulmonary sarcomatoid carcinomas are largely unknown. Thirty-three cases of pulmonary sarcomatoid carcinoma were tested for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinosarcoma

Share to Immunohistochemistry

Share to In Situ Hybridization, Fluorescence

Share to Lung Neoplasms

Share to Molecular Targeted Therapy

Share to Predictive Value of Tests

Source

Identifiers

PMID: 27174587
DOI: 10.1038/modpathol.2016.89

Genes

ALK
BRAF
KRAS
NRAS
AKT1
JAK3
EGFR
ATM
ERBB2
KIT
MET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular characterization of pulmonary sarcomatoid carcinoma: analysis of 33 cases.PMID 27174587Read ↗

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma.Semantic proximity Read ↗

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.Semantic proximity Read ↗

KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma.Semantic proximity Read ↗

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinomaSemantic proximity Read ↗

Deep Sequencing Analysis Reveals That KRAS Mutation Is a Marker of Poor Prognosis in Patients with Pulmonary Sarcomatoid Carcinoma.Semantic proximity Read ↗

New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profilesSemantic proximity Read ↗

[Pulmonary sarcomatoid carcinoma:report of three cases].Semantic proximity Read ↗

Diagnostic algorithm for detection of targetable driver mutations in lung adenocarcinomas: Comprehensive analyses of 205 cases with immunohistochemistry, real-time PCR and fluorescence in situ hybridization methods.Semantic proximity Read ↗

Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies KRAS mutation as a biomarker of poor prognosis.Semantic proximity Read ↗

Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy.Semantic proximity Read ↗

Present and future molecular testing of lung carcinoma.Semantic proximity Read ↗

Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.